ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Endocrinology, Diabetes Metabolism

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,124Medicare Part D Prescriptions Filled, Including Refills

Rank: 8 out of 448

$1.4M Total Retail Price of All Prescriptions

Rank: 11 out of 448

586 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
95% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

2% of this provider’s 15,063 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

35% of this provider’s prescriptions were for brand-name drugs, compared to an average of 45%.

Prescription Price

$82 was the average price of a prescription from this provider, compared to $111 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
METFORMIN HCL 1,050 881 1 2
LEVOTHYROXINE SODIUM 822 667 2 1
SIMVASTATIN 782 709 3 4
ATORVASTATIN CALCIUM 665 561 4 13
PEN NEEDLE 601 477 5 5
JANUVIA 532 523 6 6
FUROSEMIDE 523 497 7 25
HUMALOG 501 411 8 11
LANTUS SOLOSTAR 500 392 9 10
OMEPRAZOLE 487 450 10 21
GLIMEPIRIDE 475 436 11 7
ALENDRONATE SODIUM 455 417 12 17
LANTUS 440 384 13 8
AMLODIPINE BESYLATE 423 387 14 12
LOSARTAN POTASSIUM 415 387 15 16
METOPROLOL SUCCINATE 368 346 16 39
DIOVAN 311 288 17 23
INSULIN SYRINGE 292 244 18 9
PRAVASTATIN SODIUM 268 225 19 31
TRAMADOL HCL 243 228 20 67
GLYBURIDE 226 195 R 21 42
GABAPENTIN 211 206 22 30
NOVOLOG 182 142 23 34
ENALAPRIL MALEATE 181 177 24 81
METOPROLOL TARTRATE 180 158 25 44
SYNTHROID 164 132 26 3
NOVOLOG FLEXPEN 156 132 27 28
TRIAMTERENE-HCTZ 156 139 27 89
JANUMET 153 144 29 32
LISINOPRIL 149 135 30 14
GLIPIZIDE 149 149 30 15
FENOFIBRATE 147 101 32 59
POTASSIUM CHLORIDE 142 134 33 55
LOSARTAN-HYDROCHLOROTHIAZIDE 138 126 34 50
ZOLPIDEM TARTRATE 125 124 35 37
LIPITOR 103 85 36 56
ACTOS 101 92 37 20
PAROXETINE HCL 99 99 38 146
HYDRALAZINE HCL 97 94 39 118
ONGLYZA 93 71 40 58
DIOVAN HCT 92 79 41 61
ULTICARE 91 80 42 126
PANTOPRAZOLE SODIUM 88 77 43 62
CLOPIDOGREL 83 83 44 71
ATENOLOL 81 69 45 29
METFORMIN HCL ER 81 76 45 19
RANITIDINE HCL 77 77 47 115
PRANDIN 68 68 48 51
VYTORIN 67 67 49 107
BENAZEPRIL HCL 67 40 49 38
CYMBALTA 66 66 51 118
FORTEO 64 54 52 101
PLAVIX 63 58 53 75
CALCITRIOL 62 53 54 54
NIFEDIPINE ER 58 58 55 130
NIASPAN 56 42 56 92
TAMSULOSIN HCL 55 55 57 46
ACTONEL 53 42 58 84
LYRICA 53 53 58 155
BYETTA 52 52 60 47
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 22, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.